"Integrating Pharmacogenomics into Dental Practice: The Future of Personalized Dentistry"- A Review.

International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 1 “Integrating Pharmacogenomics into Dental Practice: The Future of Personalized Dentistry”- A Review. Dr. P. Karunakar 1 , Dr.M.G. ManojKumar 2 , Dr. T. Murali Mohan 3 , Dr. B. LakshmanaRao 4 . 1.Principal and Prof & HOD, Dept of Conservative Dentistry, Panineeya Mahavidyala Institute of Dental Sciences & Research Centre, Hyderabad, Telangana, 2. Prof & HOD, Dept of Pediatric and Preventive Dentistry, Panineeya Mahavidyala Institute of Dental Sciences & Research Centre, Hyderabad, Telangana, 3. Professor, Dept of Conservative Dentistry, Govt. Dental College and Hospital, Vijayawada, Andhra Pradesh, 4. Prof & HOD, Dept of Prosthodontics, Lenora Institute of Dental Sciences, Rajahmundry, Andhra Pradesh. ARTICLE INFO ABSTRACT ©2025 RS Publicaon Paper ID: IJPHC69047E081A71B Received: 2025-10-02 Published: 2025-11-01 DOI: https://dx.doi.org /10.5281/zenodo.17 501317 Page No: 1-13 Pharmacogenomics is a new area of study that combines genetics and pharmacology to learn how differences in people's genes affect how they respond to drugs. Pharmacogenomics is very important in dentistry since it helps choose the right drugs, the right amount, and the right treatment outcomes. This is called "precision dentistry." It aids dental professionals in anticipating patients' reactions to frequently administered medications, including analgesics, antibiotics, local anesthetics, and sedatives. For example, changes in the CYP2D6 gene change how opioids are broken down, which affects how well pain is controlled. Changes in the CYP2C19 gene change how well benzodiazepines work during sedation. Pharmacogenomic insights also help doctors decide how to treat oral cancer, periodontal disease, and implantology by finding genetic markers that are linked to medication metabolism, inflammation, and healing potential. Current research concentrates on the amalgamation of pharmacogenomic data with digital and molecular diagnostic instruments to enhance patient safety and reduce adverse medication responses. The future of pharmacogenomics in dentistry involves creating genetic tests that can be done in the chair, individualized drug regimes, and AIdriven predictive models. These will all help make treatment more predictable and improve patient satisfaction. In this way, pharmacogenomics is a big step toward personalized dental care. Key Words: Pharmacogenomics, Precision Dentistry, Genetic Variations, Personalized Therapy, Drug Response. Corresponding Author: Dr.B. LakshmanaRao Mail: [email protected] Internaonal Journal of Pharmaceucal Science and Health Care Available online on hp://www.rspublicaon.com/ijphc/index.html ISSN 2249 – 5738 Cite This Paper: Dr. P. Karunakar, Dr.M.G. ManojKumar, Dr. T. Murali Mohan and Dr. B. LakshmanaRao (2025). " “Integrang Pharmacogenomics into Dental Pracce: The Future of Personalized Denstry”- A Review.". INTERNATIONAL JOURNAL PHARMACEUTICAL SCIENCE AND HEALTH CARE (IJPHC), vol. 15, no. 5, 2025, pp. 1-13. DOI: hps://dx.doi.org/10.5281/zenodo.17501317 International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 2 Introduction Pharmacogenomics examines the influence of an individual's genetic composition on their pharmacological response. It merges pharmacology (the study of pharmaceuticals) and genomics (the study of genes and their activities) to create customized medicine, which means that the type and amount of medicine can be tailored to each person's genetic makeup for the best results with the fewest negative effects. [1,2] The idea behind pharmacogenomics is: The main idea behind pharmacogenomics is "genetic variability in drug response." Different people metabolize and respond to medications differently because of differences in their genes, notably those that code for: [1-5] 1. Enzymes that break down drugs, like the CYP450 family (CYP2D6, CYP2C9, and CYP3A4). Changes in these genes change how fast or slow the body breaks down a medicine. 2. Drug transporters, like ABCB1, which affect how drugs are absorbed and spread throughout the body. 3. Drug targets, such as polymorphisms in receptors or enzymes that influence how well drugs work. 4. Immune-related genes, such as HLA-B variations, that can predict hypersensitive reactions (e.g., HLA-B57:01* and abacavir toxicity). The goal is to be able to forecast how a patient will respond to a treatment before they take it. This will help doctors: Choose the best drug for each patient. Stay away from bad medication reactions (ADRs). Find the best dose and length of treatment. Pharmacogenomics is the basis of precision medicine, which tailors’ healthcare to each person's unique genes, environment, and way of life. [1-5] Pharmacogenomics is becoming more common in dentistry, yet it is still a new and growing subject. It helps dentists understand how genetic differences affect how patients respond to dental medications like antibiotics, local anesthetics, analgesics, and sedatives. This information helps dentists give each patient the best care possible, which reduces side effects and improves treatment outcomes. Applications of Pharmacogenomics in Dentistry [6-9] 1. Pain Management: various patients respond to painkillers (such codeine, tramadol, or NSAIDs) in various ways because of genetic differences. For example, different versions of the CYP2D6 gene affect how well codeine is turned into morphine. People who metabolize drugs poorly may not get much pain relief, whereas people who metabolize drugs very quickly may become poisonous. So, pharmacogenomic testing can help you choose the safest painkiller. International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 3 2. Local Anesthetic Response: Changes in sodium channel genes (SCN5A, SCN9A) can change how sensitive people are to local anesthetics like lidocaine or articaine. This is why some people need higher dosages or feel numb for longer. 3. The effectiveness of antibiotics and their side effects: Genes that impact medication metabolism enzymes, such CYP2C9 and CYP3A4, have an effect on how antibiotics like erythromycin or metronidazole are broken down. Genetic susceptibility to hypersensitivity reactions (e.g., to penicillin) can also be evaluated. 4. Sedation and Anxiolysis: Pharmacogenomics helps adjust the doses of sedative drugs (like benzodiazepines) based on how active CYP3A4 or CYP2C19 is. This keeps patients from being too sedated or not having enough anxiety control during operations. 5. Oral Cancer Therapy: In oral oncology and prosthodontic rehabilitation, pharmacogenomic testing assists in forecasting responses to chemotherapeutic agents and mitigating toxicity. 6. Periodontal and Bone Regeneration Therapy: Genetic variations in inflammatory cytokine genes (IL-1, TNF-α) and vitamin D receptor (VDR) genes can affect how well someone responds to periodontal or bone regenerative therapies. Pharmacogenomic insight may help choose the best anti-inflammatory or antimicrobial protocols. Problems and Difficulties: High cost and restricted access to genetic testing. Lack of awareness among dental practitioners restricted use of pharmacogenomic data in dental drug guidelines. Ethical and privacy concerns around genetic data [6-9] Advantages of Pharmacogenomics in the Dental Field Pharmacogenomics (PGx) is a tailored way to treat dental problems, where the drugs and doses are dependent on a person's genetic makeup. This method makes treatment safer, more successful, and more predictable for all types of dental care, such as oral medicine, surgery, prosthodontics, periodontics, and pediatric dentistry. 1. Customized Drug Therapy Explanation: Pharmacogenomics lets dentists provide patients medications that are right for their genetic makeup and how their bodies process and respond to them. For example, CYP2D6 polymorphisms affect how a person breaks down codeine or tramadol into active forms. Poor metabolizers → not enough pain alleviation Ultra-rapid metabolizers have a higher risk of toxicity. Advantage: It makes sure that the right medicine and dose are chosen for appropriate pain control. [6] 2. Lessening of Adverse Drug Reactions (ADRs) Genetic differences can make certain people more likely to have drug sensitivities or bad side effects. Pharmacogenomic testing aids in the identification of these risks prior to treatment. For example, the HLA-B*15:02 variant raises the risk of severe reactivity to carbamazepine, International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 4 which is used to treat orofacial neuralgia. Advantage: It lowers the risk of drug responses that could kill you and makes things safer overall. [9] 3. Better Pain and Sedation Control Explanation Pain control and sedation are important elements of dental work. Pharmacogenomics aids in ascertaining the metabolic pathways of patients concerning opioids, NSAIDs, and benzodiazepines. For example, differences in CYP3A4 and CYP2C19 impact how midazolam is broken down, which changes how deep and long it sedates. [8] Advantage: It gives good pain relief and good sedation with less adverse effects. 4. Better management of oral and periodontal diseases Genetic differences affect how the body responds to inflammation and how likely it is to get mouth infections. Pharmacogenomics assists in pinpointing patients who could benefit from tailored antiinflammatory or antibacterial treatments. For example, IL-1 gene polymorphisms raise the risk of severe periodontitis. These individuals might have a greater response to host-modulation therapy (subantimicrobial doxycycline). Advantage: It makes it easier to treat periodontal and inflammatory problems in a focused way. [10] 5. Better Implant Success and Bone Healing Explanation Genetic polymorphisms affect how bones work, how they mend after dental implants are put in, and how they integrate with other tissues. For example, variations in the vitamin D receptor (VDR) gene can change how calcium is used and how dense bones are, which can affect the success of an implant. Advantage: Pharmacogenomics can help anticipate how well an implant will work and tailor care after surgery. [11] 6. Safer Pediatric Dental Practice Explanation Genetic differences make kids process medications differently than adults. Pharmacogenomics helps choose safe painkillers and sedatives for kids who need dental work. For instance, people who are ultra-rapid metabolizers of CYP2D6 can turn too much codeine into morphine, which can slow down breathing. Advantage: It makes sure that youngsters may safely and effectively manage their pain. [12] 7. Basis for Precision Dentistry Explanation Pharmacogenomics makes precision dentistry possible by adding genetic testing to regular dental care for tailored diagnosis, prevention, and treatment. International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 5 Advantage: It improves clinical decision-making, patient happiness, and the overall results of treatment. .[13] Summary of Advantages: Advantage Clinical Example Outcome Personalized drug therapy Codeine metabolism (CYP2D6) Effective pain relief Fewer adverse reactions Carbamazepine hypersensitivity (HLAB*15:02) Improved safety Better pain control NSAID/Opioid metabolism (CYP enzymes) Optimal analgesia Periodontal disease management IL-1 genotype Targeted therapy Improved implant success VDR polymorphism Predictable osseointegration Safer pediatric care Codeine metabolism Avoid toxicity Precision dentistry Genetic profiling Personalized care Pharmacogenomics has many benefits for dentistry since it makes treatments more tailored, safer, and more predictable. It reduces side effects, improves the effectiveness of drugs, and improves results in pain control, implant success, and illness management. As pharmacogenomic testing becomes more widely available, it will be the basis for precise and preventive dental care. Applications of Pharmacogenomics in Various Dental Specialties Pharmacogenomics (PGx) has introduced the concept of personalized dentistry, where genetic variations guide the selection and dosage of drugs to achieve maximum therapeutic benefits with minimal adverse effects. 1. Oral Medicine and Oral Pathology Application: Pharmacogenomics helps find out how people react to medications that are used to treat infections, oral mucosal illnesses, and inflammatory disorders. For instance, people with specific CYP2C9 or CYP3A4 gene variations may not metabolize antifungal medicines (fluconazole, ketoconazole) quickly enough and need to change their dose. • Genetic testing for HLA-B*15:02 can help doctors figure out if a person is likely to have an allergic reaction to carbamazepine, which is sometimes given to people with trigeminal neuralgia. Advantage: Better drug safety and fewer bad drug interactions. [9] International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 6 2. Oral and Maxillofacial Surgery Application: PGx helps choose the best painkillers, sedatives, and anesthetics to utilize during and after surgery. For example, the CYP2D6 polymorphism changes codeine into morphine, which means that people who don't metabolize it well have trouble controlling their pain. Changes in CYP3A5 alter how midazolam is broken down, which changes how deep and how long the sedation lasts. Mutations in SCN9A (the gene for the voltage-gated sodium channel) may change how sensitive a person is to local anesthetics, which could explain why some people don't feel pain or stay numb for a long time. Benefit: Customized anesthetic and pain management plans make the recovery process more comfortable and safer. [6] 3. Periodontics Application: Pharmacogenomic testing can identify patients prone to severe inflammation and bone loss, hence informing treatment selection in periodontal therapy. IL-1 gene polymorphisms are linked to an increased inflammatory response in periodontitis. Patients with these variants may benefit from host-modulation therapy (sub-antimicrobial doxycycline) or tailored antibiotic regimens. Advantage: Forecasting disease advancement and customizing anti-inflammatory or antibacterial therapies. [10] 4. Pediatric Dentistry Application: Helps figure out what the safe amounts of painkillers and sedatives are for kids based on how their bodies break down drugs. For instance, CYP2D6 ultra-rapid metabolizers may change codeine into morphine too quickly, which can cause breathing problems. Because of this, codeine is not given to children with this genotype. CYP2C19 and CYP3A4 affect how well midazolam works for sedation. Benefit: Makes ensuring that pain control and behavior management are safe and effective. [12] 5. Prosthodontics Application: PGx helps with pain, infection, and tissue healing that happen when you get dentures, have implant surgery, or have maxillofacial prosthetic therapy. Examples: Choosing an analgesic following implant placement based on the CYP2D6 genotype. Genetic propensity to inadequate bone metabolism (VDR gene variations) may influence osseointegration efficacy. International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 7 Advantage: Improved implant success and increased comfort after prosthetic surgery. [11] 6. Oral Oncology Application: Pharmacogenomics is essential for customizing chemotherapeutic agents for the treatment of oral cancer. For example, checking for TPMT and DPYD gene polymorphisms stops severe toxicity by affecting the metabolism of 6-mercaptopurine and 5-fluorouracil, respectively. Variations in EGFR and CYP1A2 affect how well tyrosine kinase inhibitors and other targeted medicines work. Advantage: Better control of cancer with less harmful drugs. [14] 7. Endodontics Application: Knowing about genetic differences can help with pain management and infection control during root canal therapy. Examples: Variants in CYP2D6 and OPRM1 influence the reaction to opiates administered for endodontic pain. Polymorphisms in inflammatory genes (IL-1β, TNF-α) may affect how well periapical healing goes. [15] Dental Specialty Key Genes/Drugs Affected Outcome/Use Oral Medicine CYP2C9, HLA-B*15:02 Don't be sensitive to drugs. Oral Surgery CYP2D6, SCN9A Make anesthetic and pain relief as good as they can be Periodontics IL-1, TNF-α Guess how bad the condition is and how well the drugs will work Pediatric Dentistry CYP2D6, CYP2C19 Safe sedation and pain relief Prosthodontics CYP2D6, VDR Pain management and success with implants Oral Oncology TPMT, DPYD Guess how the chemo will work and how nasty it will be. Endodontics OPRM1, IL - 1β Better healing and pain management Pharmacogenomics is changing dentistry by using genetic information to help make therapeutic decisions. It helps dentists guess how a certain patient will respond to a drug, lowers side effects, and makes treatments safer and more effective in all areas of dentistry. As genetic testing becomes increasingly common, pharmacogenomics will become an important part of precision dentistry. International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 8 Role of Pharmacogenomics in Dental Implantology Pharmacogenomics (PGx) is becoming more and more important in dental implantology since it can help make implant therapy more individualized. Pharmacogenomics helps doctors improve implant success, osseointegration, and post-operative care by looking at the genetic differences that affect medication metabolism, bone healing, and immune responses. 1. Role in Osseointegration and Bone Metabolism Genetic differences affect how bones grow and change shape around an implant.Pharmacogenomic testing can find patients whose bone metabolism has changed or whose osseointegration has been delayed. Important Genetic Markers and Their Effects: Vitamin D Receptor (VDR) gene polymorphisms: Influence calcium absorption and bone remodeling. Some variations (VDR FokI, TaqI, BsmI) are linked to poorer rates of implant success. Genes for estrogen receptors (ESR1) and collagen (COL1A1): Affect bone density and the healing process. IL-1 and TNF-α gene polymorphisms: Heighten inflammatory response, resulting in an elevated risk of peri-implantitis and bone resorption. Clinical Impact: Helps find people who need vitamin D or anti-inflammatory drugs before getting an implant. Helps in treatment planning and predicts the outcome of the implant. [16] 2. Role in Drug Metabolism and Postoperative Medication Patients frequently receive analgesics, antibiotics, and anti-inflammatory medications postimplant surgery. Genetic variations in enzymes that break down drugs change how these drugs act. For example: CYP2D6 variants: Affect how the body breaks down codeine, tramadol, and other opioids used to relieve pain. People who don't metabolize well have trouble controlling their pain. People who metabolize drugs very quickly are more likely to be hazardous. CYP2C9 and CYP3A4: Change how NSAIDs (like ibuprofen and diclofenac) work to relieve pain after surgery. People who don't metabolize drugs well are more likely to have gastrointestinal or kidney adverse effects. CYP2C19: Affects how metronidazole and omeprazole are broken down, which affects antibiotic treatment. Clinical Impact: Allows for dose changes or the choice of a different medicine to better manage pain and healing after an implant. [6] International Journal of Pharmaceutical Science and Health Care Volume 15, Number 6, 2025 Available online on http://www.rspublication.com/ijphc/index.html ISSN 2249 – 5738 DOI: 10.5281/zenodo.17360940 Original Article ©2025 RS Publicaon, rspublica[email protected] 9 3. Role in Managing Peri-Implant Inflammation and Failure Genetic predispositions to heightened inflammatory responses may result in peri-implant mucositis and peri-implantitis. Important Genes: IL-1α and IL-1β polymorphisms: Strongly associated with heightened bone resorption and implant failure. TNF-α polymorphism: Raises levels of pro-inflammatory cytokines, which slows down the healing of wounds. Clinical Impact: PGx testing can find individuals who are at high risk and need tight plaque control, anti-inflammatory medication, or maintenance regimens. Could affect the choice of implant surface and the way loads are applied. [17] 4. Role in Predicting Implant Success and Long-Term Stability Pharmacogenomic markers can assist predict long-term results by connecting genetic features to how well an implant works and the quality of the bone. Examples: Variations in the MMP-8 and RANKL/OPG genes change how bones rebuild and how soft tissues respond. Polymorphisms in CYP1A1 may change how oxidative stress and tissue repair work around implants. Clinical Impact: Personalized preoperative assessment guarantees treatment solutions tailored to each patient, improving long-term success rates. [11] 5. Role in Future Precision Implantology Pharmacogenomics is the basis of precision implantology. It combines genomic data with digital planning and the choice of biomaterials. When PGx is used with biomarkers, AI, and regenerative medicine, it could change the way implants work. Future Possibilities: DNA-driven design of implant surfaces • Genetically guided biomaterials and growth factors Incorporation of pharmacogenomic testing into digital implant planning systems [8] Pharmacogenomics gives individualized dental implant therapy a scientific basis. It can help predict: How well the implant will heal and osseointegrate, how well it will respond to pain control and antibiotics. The risk of inflammation and implant failure.